Skip to content
To the full analysis

Avita Medical stock: balance sheet and debt

RCEL
$16.20Closing price of 12 Nov 2026MEQIRI Score 47 out of 100

Avita Medical has a debt to equity ratio of −2.77.

Daily figure as of 13 Nov 2026

Debt / Equity
−2.77
Interest coverage
−8.7x
Current ratio
0.57
Cash & equivalents
$18.19M
Total assets
$56.39M
Equity ratio
−29.5%
Goodwill and intangible assets
$5.65M
not split out
Net debt
$27.86M

Total assets and equity ratio

How large the balance sheet of Avita Medical Inc. is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$14.2M$4.63Mnot split out91.1%−$12.31M
2007$16.14M$4.4Mnot split out83.9%−$9.18M
2008$9.93M$3.84Mnot split out87.4%−$3.92M
2009$9.31M$3.22Mnot split out50.6%−$4.1M
2010$17.47M$2.58Mnot split out90.9%−$12.72M
2011$10.58M$72.12Knot split out79.9%−$8.13M
2012$13.95Mnot reported separatelynot reported separately81.0%−$11.48M
2013$7.78Mnot reported separatelynot reported separately75.6%−$3.88M
2014$7.15Mnot reported separatelynot reported separately77.5%−$3.9M
2015$11.53Mnot reported separatelynot reported separately79.7%−$5.59M
2016$10.01Mnot reported separatelynot reported separately66.8%−$4.95M
2017$31.24Mnot reported separatelynot reported separately82.5%−$19.94M
2018$25.78M$225Knot split out80.8%−$20.17M
2019$82.46M$364Knot split out87.8%−$71.72M
2020$125.5M$472Knot split out92.2%−$109.87M
2022$98.26M$465Knot split out86.2%−$78.42M
2023$111.64M$487Knot split out43.9%−$46.65M
2024$79.71M$5.57Mnot split out5.6%$10.1M
2025$56.39M$5.65Mnot split out−29.5%$27.86M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$12.31M$12.94M$00
2007$9.23M$13.49M$52.43K0
2008$3.92M$8.67M$00
2009$4.1M$4.71M$00
2010$12.72M$15.88M$00
2011$8.13M$8.45M$00
2012$11.48M$11.3M$00
2013$3.88M$5.88M$00
2014$3.9M$5.54M$00
2015$5.59M$9.18M$00
2016$4.95M$6.69M$00
2017$20.12M$25.79M$182.32K0.01
2018$20.17M$20.83M$00
2019$73.64M$72.4M$1.92M0.03
2020$110.75M$115.66M$878K0.01
2022$79.34M$84.74M$918K0.01
2023$89.06M$49.06M$42.41M0.86
2024$35.89M$4.5M$45.99M10.22
2025$18.19M−$16.65M$46.05M−2.77

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 31 Aug 2023)
  • Valuation signal Fairly valued since 13 Nov 2026, previously Overvalued
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy